{IMAGERIGHT:http://www.massdevice.com/sites/default/wp-content/uploads/checkup/090616_index.jpg}Our Weekly Checkup takes the temperature of the 63 public medical device companies in the MassDevice Index. The index is weighted according to market capitalization, based on the number of shares outstanding for each company from its most recent quarterly report and each Friday’s closing share price.
The index for the week ended June 12 closed with a reading of 5.39, down just less than 1 percent compared with the prior week. Since we began tracking these companies in late March, the index has risen 10.8 percent.
The Weekly Checkup also compares Monday morning’s opening share prices with their value when the markets close Friday afternoon to calculate the biggest gainers and losers.
Here are the ten firms that posted the biggest share price gains and losses during the week ended June 12:
The five biggest gainers:
- LeMaitre Vascular Inc. 21.67% (open $3.00; close $3.65)
- NMT Medical Inc. 21.47% (open $1.63; close $1.98)
- Biopure 18.37% (open $0.25; close $0.29)
- NeuroMetrix Inc. 18.08% (open $1.77; close $2.09)
- Cambridge Heart Inc. 15.00% (open $0.10; close $0.12)
And the five biggest losers:
- Optos Inc. -20.67% (open $75.00; close $59.50)
- Advansource Biomaterials Corp. -20.00% (open $0.45; close $0.36)
- Acusphere -18.75% (open $0.24; close $0.20)
- Quick-Med Technologies Inc. -14.19% (open $0.62; close $0.53)
- Pressure BioSciences Inc. -13.89% (open $1.80; close $1.55)
The checkup also takes a look at a different financial metric each week, ranking local players based their performance in that category.
This week we’re looking at the “quick ratio,” otherwise known as the acid test, which determines whether a company’s current assets can meet current obligations. It’s calculated by dividing current assets (minus inventories) by current liabilities.
We put the companies in the MassDevice Index to the acid test. Here are the top 20 public medical device companies in Massachusetts when it comes to the quick ratio:
- Heartware International Inc. 5.87
- Palomar Medical Technologies Inc. 5.84
- AdvanSource Biomaterials Corp 5.32
- Psychemedics Corp. 4.85
- BioSphere Medical Inc. 4.12
- Insulet Corp. 4.04
- Cambridge Heart Inc. 3.96
- Clinical Data Inc. 3.34
- LeMaitre Vascular Inc. 3.34
- Vision-Sciences Inc. 2.75
- iCad inc. 2.71
- MKS Instruments Inc. 2.69
- Haemonetics Corp. 2.60
- Harvard Bioscience Inc. 2.57
- Waters Corp. 2.49
- Cynosure Inc. 2.36
- NeuroMetrix Inc. 1.99
- Brooks Automation Inc. 1.81
- Thermo Fisher Scientific Inc. 1.79
- UFP Technologies Inc. 1.78
Source: Mergent Inc.
Disclaimer: MassDevice.com’s rankings do not reflect an opinion of companies’ health, prospects or viability. They are intended to provide a snapshot of publicly traded medical device companies and in no way constitute a recommendation to buy or sell any particular security, portfolio of securities, transaction or investment strategy.
